Compounds that directly induce expression of A2A receptors on neutrophils such as LPS, or those that elicit the release of cytokines like TNF-α, Interleukin 1β (IL-1β) [36], may be useful as prophylactic neuroprotectants by reprogramming the response of neutrophils to stroke. This evidence concerns the gene TNF and Stroke.